UNSPSC 51282701: Teicoplanin

This classification denotes an antibiotic with the molecular formula C58H42CL2N7O18(R1)(R2)(R3), a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U3D3YY81M, more generally known as teicoplanin. European Medicines Agency schedules teicoplanin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04714MIG. The term TEICOPLANIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.

TEICOPLANIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule teicoplanin under HS 29419000 and SITC 54139. As of Q4 2014, TEICOPLANIN remains the US FDA Preferred Term for this commodity. Teicoplanin bears US NLM identifiers UMLS ID C0145106 and NCI Concept Code C1412.

UNSPSC 51282701 Teicoplanin is a Commodity code designating a specific pharmaceutical product, but recent state and local solicitations tagged with this code show minimal alignment with teicoplanin procurement and instead reflect broader pharmaceutical, medical supply, and pharmacy benefit program activity. The code sees use across state health agencies, county health departments, and municipal fire departments procuring medical supplies, naloxone, pharmaceutical products through cooperative purchasing vehicles, and pharmacy benefit program services. Work being solicited ranges from first-aid and emergency medical supplies for fire rescue operations to generic multi-source pharmaceuticals distributed through authorized wholesalers to pharmacy benefit initiatives and direct-to-manufacturer prescription programs.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida released IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The City of Tampa's Purchasing Department issued ITB 26P00145 in March 2026 for medical and first aid supplies totaling 169 line items for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000 and a response deadline of March 13, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, with a response deadline of April 3, 2026. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, released RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and award effective July 1, 2026.